ENTITY
Macrogen Inc

Macrogen Inc (038290 KS)

8
Analysis
Health CareSouth Korea
Macrogen Inc. provides DNA sequencing and genome research services. The Company also raises and sells transgenic and knockout mice to biotechnology institutes and pharmaceutical companies. Macrogen develops DNA chips, which are used to improve the diagnosis and treatment of disease as well.
more
16 Dec 2024 17:46

DNA Synthesis with a Silicon Twist

Twist's fast, cheap DNA synthesis will power biotech start-ups, driving demand, fostering loyalty, enabling innovation, and securing new and...

Logo
223 Views
Share
26 Nov 2020 21:49
Smartkarma Originals

Asian Healthcare - Coming of Age

This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...

Share
11 Mar 2020 00:58

Full Details & Current Designation List - Short-Selling Restriction Rule Change in Korea

It is now official that we have a new short-selling restriction rule, which is effective as of March 11. For the existing regulations, we now have...

Logo
351 Views
Share
bullishMacrogen Inc
20 Jul 2018 16:20

CV Note: Macrogen (038290 KQ)

"Korea’s #1 and the world’s #5 NGS player" The world’s 5th ranked DNA sequencing service provider. Growing NGS (Next Generation Sequencing) market...

Logo
587 Views
Share
bearishCelltrion Inc
10 Aug 2017 19:54

NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move

Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...

Logo
1.4k Views
Share
x